Kathryn Anastos

Summary

Affiliation: Montefiore Medical Center
Country: USA

Publications

  1. pmc The S40 residue in HIV-1 Gag p6 impacts local and distal budding determinants, revealing additional late domain activities
    Susan M Watanabe
    Department of Molecular Genetics and Microbiology, Stony Brook University, Life Sciences Bldg, Rm 248, Stony Brook, NY 11794 5222, USA
    Retrovirology 10:143. 2013
  2. ncbi request reprint Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens
    Kathryn Anastos
    Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 45:34-42. 2007
  3. ncbi request reprint Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy
    Kathryn Anastos
    Women s Interagency HIV Study, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 35:383-92. 2004
  4. ncbi request reprint Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Belfer 1308, Bronx, NY 10461, USA
    J Natl Cancer Inst 97:577-86. 2005
  5. ncbi request reprint Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women
    Tiffany G Harris
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    AIDS 21:1933-41. 2007
  6. pmc The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    J Infect Dis 203:1807-14. 2011
  7. pmc Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Belfer Building, Room 1308, 1300 Morris Park Ave, Bronx, NY 10461, USA
    J Virol 85:10826-33. 2011
  8. ncbi request reprint Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women
    Nicolas F Schlecht
    Albert Einstein College of Medicine, Department of Epidemiology and Population Health, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    J Gen Virol 86:2709-20. 2005
  9. doi request reprint Insulin-like growth factor axis and oncogenic human papillomavirus natural history
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 17:245-8. 2008
  10. pmc Marginal and mixed-effects models in the analysis of human papillomavirus natural history data
    Xiaonan Xue
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Belfer 1308, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 19:159-69. 2010

Detail Information

Publications95

  1. pmc The S40 residue in HIV-1 Gag p6 impacts local and distal budding determinants, revealing additional late domain activities
    Susan M Watanabe
    Department of Molecular Genetics and Microbiology, Stony Brook University, Life Sciences Bldg, Rm 248, Stony Brook, NY 11794 5222, USA
    Retrovirology 10:143. 2013
    ..Here, we report that a conserved Gag p6 residue, S40, impacts budding mediated by all of these determinants...
  2. ncbi request reprint Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens
    Kathryn Anastos
    Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 45:34-42. 2007
    ..The effects of HIV infection, highly active antiretroviral therapy (HAART), and specific antiretroviral agents on lipoproteins in women are not well described...
  3. ncbi request reprint Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy
    Kathryn Anastos
    Women s Interagency HIV Study, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 35:383-92. 2004
    ..If delayed-type hypersensitivity (DTH) response predicts clinical response in persons using highly active antiretroviral therapy (HAART), it may also prove useful in resource-poor settings...
  4. ncbi request reprint Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Belfer 1308, Bronx, NY 10461, USA
    J Natl Cancer Inst 97:577-86. 2005
    ....
  5. ncbi request reprint Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women
    Tiffany G Harris
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    AIDS 21:1933-41. 2007
    ..This study assessed the relationship of anergy test results with cervical infection by human papillomavirus (HPV) and cervical neoplasia in HIV-seropositive and seronegative women...
  6. pmc The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    J Infect Dis 203:1807-14. 2011
    ....
  7. pmc Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Belfer Building, Room 1308, 1300 Morris Park Ave, Bronx, NY 10461, USA
    J Virol 85:10826-33. 2011
    ..4; 95% CI = 0.1 to 1.0; P = 0.04) was associated with low odds of an immunological response. The associations of HLA genotype with HIV disease are different and sometimes even opposite in treated and untreated patients...
  8. ncbi request reprint Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women
    Nicolas F Schlecht
    Albert Einstein College of Medicine, Department of Epidemiology and Population Health, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    J Gen Virol 86:2709-20. 2005
    ..If non-European variants are more oncogenic, the effect may involve a late stage in cervical tumorigenesis...
  9. doi request reprint Insulin-like growth factor axis and oncogenic human papillomavirus natural history
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 17:245-8. 2008
    ..07; 95% CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV...
  10. pmc Marginal and mixed-effects models in the analysis of human papillomavirus natural history data
    Xiaonan Xue
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Belfer 1308, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 19:159-69. 2010
    ..Overall, the results show that marginal and mixed-effects models are efficient for studying HPV natural history, but also highlight the importance of understanding how these models differ...
  11. pmc Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study
    Christina M Parrinello
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Belfer 1306C, Bronx, NY 10461, USA
    Atherosclerosis 225:408-11. 2012
    ..We examined serum lipids in association with carotid artery intima-media thickness (CIMT) in HIV-infected and HIV-uninfected women...
  12. pmc Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection
    Marla J Keller
    Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave, Mazer Bldg, Room 512, Bronx, NY 10461, USA
    JAMA 308:362-9. 2012
    ..Whether a 3-year or 5-year screening interval could be used in HIV-infected women who are cytologically normal and oncogenic HPV-negative is unknown...
  13. pmc Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
    Robert C Kaplan
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    AIDS 22:1615-24. 2008
    ..To assess the association of HIV infection, HIV disease parameters (including CD4+ T-cell counts, HIV viral load, and AIDS) and antiretroviral medication use with subclinical carotid artery atherosclerosis...
  14. pmc The impact of HIV status, HIV disease progression, and post-traumatic stress symptoms on the health-related quality of life of Rwandan women genocide survivors
    Tracy L Gard
    Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA
    Qual Life Res 22:2073-84. 2013
    ..Additionally, this study attempted to clarify whether post-traumatic stress symptoms were uniquely associated with HQOL or confounded with depression...
  15. pmc Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment
    Robert C Kaplan
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    J Acquir Immune Defic Syndr 60:359-68. 2012
    ..We examined atherogenic biomarkers and subclinical atherosclerosis in HIV-infected adults before and after beginning highly active antiretroviral therapy (HAART)...
  16. ncbi request reprint Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    JAMA 293:1471-6. 2005
    ....
  17. pmc Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women
    David B Hanna
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Department of Medicine, Cook County Health and Hospitals System and Rush University, Chicago, IL City of Hope National Medical Center, Duarte, CA Department of Community Health Sciences, SUNY Downstate Medical Center, Brooklyn, NY Department of Medicine, Georgetown University Medical Center, Washington, DC and Department of Medicine, Montefiore Medical Center, Bronx, NY
    J Acquir Immune Defic Syndr 65:587-96. 2014
    ..The use of single-tablet antiretroviral therapy (ART) regimens and its implications on adherence among HIV-infected women have not been well described...
  18. pmc Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States
    Kerry Murphy
    aAlbert Einstein College of Medicine Montefiore Medical Center, Bronx, New York bRutgers University, Piscataway, New Jersey cSchool of Health Sciences and Practice New York Medical College, Valhalla, New York dCook County Health and Hospitals System eRush University, Chicago, Illinois fUniversity of California San Francisco, San Francisco, California gJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland hState University of New York Downstate Medical Center, Brooklyn, New York, USA iUniversity of Gothenburg, Gothenburg, Sweden jUniversity of Southern California, Los Angeles, California kGeorgetown University, Washington, District of Columbia, USA
    AIDS 27:2413-23. 2013
    ..To assess the association of race with clinical outcomes in HIV-positive women on continuous HAART...
  19. pmc Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study
    Christina M Parrinello
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA
    AIDS 27:1516-9. 2013
    ..Thus, it remains unknown whether short-term treatment-related changes in standard risk factors may appreciably change risk of cardiovascular disease (CVD). ..
  20. ncbi request reprint The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women
    Kathryn Anastos
    Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 39:537-44. 2005
    ..To determine the association of race with clinical and laboratory outcomes after initiation of highly active antiretroviral therapy (HAART) in HIV-1-infected women in the United States...
  21. pmc Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women
    Howard D Strickler
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    J Infect Dis 197:319-27. 2008
    ....
  22. pmc The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    AIDS 22:527-31. 2008
    ..To investigate the role of the IGF axis in hepatitis C virus (HCV)-related liver disease among high-risk patients, we prospectively evaluated HCV-viremic/HIV-positive women...
  23. ncbi request reprint The association of bone mineral density with HIV infection and antiretroviral treatment in women
    Kathryn Anastos
    Montefiore Medical Centre, Bronx, NY, USA
    Antivir Ther 12:1049-58. 2007
    ..Low bone mineral density (BMD) has been reported in HIV-infected women and men...
  24. ncbi request reprint The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy
    Kathryn Anastos
    Montefiore Medical Center, Bronx, New York, USA
    Ann Intern Med 140:256-64. 2004
    ..The prognostic value of CD4+ cell counts and HIV-1 RNA levels attained after the initiation of highly active antiretroviral therapy (HAART) compared with before the initiation of HAART has not been well defined...
  25. ncbi request reprint Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease
    Kathryn Anastos
    Department of Internal Medicine, Montefiore Medical Center and Lincoln Medical and Mental Health Center, Bronx, NY 10451, USA
    Arch Intern Med 162:1973-80. 2002
    ..The optimal virologic and immunologic stage at which to initiate antiretroviral therapy in individuals infected with human immunodeficiency virus type 1 (HIV-1) is undefined...
  26. pmc Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY Department of Medicine, Montefiore Medical Center, Bronx, NY Department of Pediatrics, University of Southern California, Los Angeles, CA Department of Medicine, University of California San Francisco, San Francisco, CA Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Department of Medicine, CORE Center Stroger Hospital of Cook County, Chicago, IL Department of Medicine, Georgetown University Medical Center, Washington, DC Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY Department of Immunology Microbiology, Rush University Medical Center, Chicago, IL and Division of Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Faculty of Science, Utrecht University, The Netherlands
    J Acquir Immune Defic Syndr 67:295-303. 2014
    ..Studies in HIV positives did not address overall immune status (total CD4⁺ count)...
  27. pmc Association of markers of hemostasis with death in HIV-infected women
    Elizabeth Kiefer
    John A Burns School of Medicine, University of Hawaii, Honolulu, HI Institute for Health, Health Care Policy and Aging Research, Rutgers University, Piscataway, NJ New York Medical College, Valhalla, NY Albert Einstein College of Medicine, Bronx, NY State University at Downstate Medical Center, Brooklyn, NY Stroger Hospital and Rush University, Chicago, IL John Hopkins Bloomberg School of Public Health, Baltimore, MD Georgetown University, Washington, DC Los Angeles County and University of Southern California Medical Center, Los Angeles, CA University of California, San Francisco, San Francisco, CA University of Vermont, Burlington, VT and Montefiore Medical Center, Bronx, NY
    J Acquir Immune Defic Syndr 67:287-94. 2014
    ..Given longer survival on highly active antiretroviral therapy, further studies of these markers are needed to determine their prognostic value. ..
  28. pmc Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women
    Betsy C Herold
    Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    J Acquir Immune Defic Syndr 63:485-93. 2013
    ....
  29. pmc Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Hepatology 51:1514-22. 2010
    ..We additionally studied the relation of HLA alleles with HCV infection (serostatus) in women at high risk of HCV from injection drug use (N = 838), but no significant relationships were observed...
  30. pmc Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women
    Marla J Keller
    Albert Einstein College of Medicine, Bronx, NY, USA
    Am J Reprod Immunol 75:631-42. 2016
    ..Stability over time of systemic and mucosal immunity and their associations with bacterial vaginosis (BV) and HIV-specific parameters were assessed...
  31. pmc Sexual Behavior and Risk Practices of HIV Positive and HIV Negative Rwandan Women
    Adebola A Adedimeji
    Centre for Public Health Sciences, Albert Einstein College of Medicine, Mazer 515, 1300 Morris Park Avenue, Bronx, NY, 10461, USA
    AIDS Behav 19:1366-78. 2015
    ..HIV positive women with a history of sexual violence in the contexts of war and conflict may be susceptible to some high-risk sexual behaviors...
  32. pmc T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS
    Roksana Karim
    Maternal, Child and Adolescent Center for Infectious Disease and Virology, Department of Pediatrics, University of Southern California, Los Angeles, CA Department of Preventive Medicine, University of Southern California, Los Angeles, CA Atherosclerosis Research Unit, University of Southern California, Los Angeles, CA Department of Medicine, University of California, San Francisco, San Francisco, CA Medical Service, Department of Veterans Affairs, University of California, San Francisco, San Francisco, CA Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, NY Georgetown University Medical Center, Georgetown University, Washington, DC Departments of Medicine, Stroger Hospital and Rush University, Chicago, IL Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
    J Acquir Immune Defic Syndr 67:349-56. 2014
    ..We hypothesized that T-cell activation will predict vascular stiffness, a measure of subclinical atherosclerosis...
  33. pmc Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women
    Sanjiv M Baxi
    aDepartment of Medicine bDepartment of Clinical Pharmacy cDepartment of Epidemiology and Biostatistics, University of California San Francisco UCSF, San Francisco, California dDepartment of Medicine, SUNY Downstate Medical Center, Brooklyn, New York eDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco UCSF, San Francisco, California fDepartment of Medicine, Albert Einstein University, Bronx, New York gDepartment of Medicine, Stroger Hospital and Rush University, Chicago, Illinois hDepartment of Medicine, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland iDepartment of Medicine, Georgetown University Medical Center, Washington DC jSection of General Internal Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA
    AIDS 28:59-66. 2014
    ..Tenofovir is used commonly in HIV treatment and prevention settings, but factors that correlate with tenofovir exposure in real-world settings are unknown...
  34. pmc Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS)
    Ikwo Oboho
    Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, The Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD Departments of Medicine, Epidemiology and Population Health, Montefiore Medical Center, Bronx, NY Department of Medicine, State University of New York Health Science Center, Brooklyn, NY Department of Medicine, Georgetown University Medical Center, Washington, DC Department of Medicine, Division of Hematology, University of Southern California, Los Angeles, CA Department of Medicine, University of California San Francisco, San Francisco, CA Department of Medicine, Cook County Hospital, Chicago, IL Department of Pharmacovigilance, Pharmaceutical Product Development, Morrisville, NC
    J Acquir Immune Defic Syndr 62:388-95. 2013
    ..We examined several urinary biomarkers to determine if rises accompanying TDF initiation preceded creatinine changes...
  35. pmc Association of pre-treatment nutritional status with change in CD4 count after antiretroviral therapy at 6, 12, and 24 months in Rwandan women
    Elizabeth Kiefer
    Montefiore Medical Center, Bronx, New York, USA
    PLoS ONE 6:e29625. 2011
    ..We hypothesized that poorer nutritional status would be associated with smaller gains in CD4 count in Rwandan women initiating ART...
  36. pmc Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection
    Audrey L French
    CORE Center Stroger Hospital of Cook County, Chicago, IL Department of Medicine, Rush University Medical Center, Chicago, IL Department of Medicine, Georgetown University Medical Center, Washington, DC Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA Department of Medicine, State University of New York, Downstate, Brooklyn, NY Department of Medicine, Montefiore Medical Center, Bronx, NY Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Institute for Liver and Digestive Health, Division of Medicine, University College London, London, United Kingdom and Department of Medicine, University of California San Francisco, San Francisco, CA
    J Acquir Immune Defic Syndr 72:274-80. 2016
    ..We studied HIV/hepatitis C virus (HCV)-infected women over time to determine whether the trajectory of liver disease progression is affected by isolated anti-HBc serologic status...
  37. pmc Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women
    Niall Buckley
    Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA
    Am J Reprod Immunol 75:146-54. 2016
    ..High-risk human papillomavirus (HR-HPV) is prevalent in HIV-infected women and may be associated with mucosal changes that promote HIV replication...
  38. pmc Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer
    Jeny Ghartey
    Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY Department of Obstetrics and Gynecology and Women s Health, Montefiore Medical Center, Bronx, NY Department of Pediatrics, University of Southern California, Los Angeles, CA Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, NY Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD Department of Health and Human Services, National Institute of Child Health and Human Development, Bethesda, MD Department of Hematology, City of Hope National Medical Center, Duarte, CA Department of Obstetrics and Gynecology, Georgetown University Medical Center, Washington, DC Department of Pathology, University of Alabama, Birmingham, AL and Department of Medicine, University of California, San Francisco, CA
    J Acquir Immune Defic Syndr 66:316-23. 2014
    ..However, little is known regarding local genital tract HIV RNA levels and their relation with cervical HPV and neoplasia...
  39. pmc Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women
    Todd H Driver
    aSchool of Medicine bDepartment of Medicine cDepartment of Epidemiology and Biostatistics, San Francisco Veterans Affairs Medical Center, University of California, San Francisco, California dDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland eSection of Nephrology, Department of Medicine fProgram of Applied Translational Research, Yale University, New Haven, Connecticut gClinical Immunology Research Laboratory, University of California, Los Angeles, California hDepartments of Medicine and of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York iDepartments of Medicine, Stroger Hospital and Rush University, Chicago, Illinois jUniversity of Southern California, Los Angeles, California kDivision of Infectious Diseases, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York lGeorgetown University Medical Center, Washington, DC, USA
    AIDS 27:2291-9. 2013
    ..Cystatin C could improve chronic kidney disease (CKD) classification in HIV-infected women relative to serum creatinine...
  40. pmc Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women
    Kathryn Anastos
    Montefiore Medical Center, Bronx NY, USA
    AIDS Res Ther 7:34. 2010
    ..Lipoprotein profiles in HIV-infected African women have not been well described. We assessed associations of lipoprotein levels and cardiovascular risk with HIV-infection and CD4 count in Rwandan women...
  41. pmc Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women
    Kathryn Anastos
    Departments of Medicine and Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, United States of America
    PLoS ONE 5:e13525. 2010
    ..We examined factors associated with cervical intraepithelial neoplasia grade 3 or cancer (CIN3+) in Rwandan women infected with both HIV and HPV (HIV+/HPV+)...
  42. pmc Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY Infections and Immunoepidemiology Branch, National Cancer Institute, Bethesda, MD Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY Department of Medicine, Georgetown University Medical Center, Washington, DC Department of Pediatrics, University of Southern California, Los Angeles, CA Department of Medicine, University of California, San Francisco, CA Department of Medicine, CORE Center Stroger Hospital of Cook County, Chicago, IL Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD and Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
    J Acquir Immune Defic Syndr 72:162-70. 2016
    ..The relation of hepatitis C virus (HCV) coinfection with the CD4/CD8 ratio in HIV+ patients is unknown...
  43. pmc Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study
    Zaher O Merhi
    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York 10461, USA
    Fertil Steril 98:228-34. 2012
    ..To study the correlation between circulating 25-hydroxyvitamin D (25OH-D) levels and serum antimüllerian hormone (AMH) in women enrolled in the Women's Interagency HIV Study...
  44. pmc Differences in the Nonuse of any Contraception and Use of Specific Contraceptive Methods in HIV Positive and HIV Negative Rwandan Women
    Adebola A Adedimeji
    Centre for Public Health Sciences, Albert Einstein College of Medicine, Mazer 515, 1300 Morris Park Avenue, Bronx, NY 10461, USA Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    AIDS Res Treat 2012:367604. 2012
    ..Important differences exist between HIV-positive and HIV-negative women with regard to contraceptive method use that should be addressed by interventions seeking to improve contraceptive prevalence...
  45. ncbi request reprint Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women
    Howard D Strickler
    Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    J Natl Cancer Inst 95:1062-71. 2003
    ..To address this issue, we examined HPV test results from repeated study visits in the WIHS and from an independent study, the HIV Epidemiology Research Study (HERS)...
  46. pmc Decentralizing Maternity Services to Increase Skilled Attendance at Birth and Antenatal Care Utilization in Rural Rwanda: A Prospective Cohort Study
    Lisa M Nathan
    Department of Obstetrics, Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Matern Child Health J 19:1949-55. 2015
    ..Decentralization of services may be one strategy to increase rates of SAB and ANC utilization, but selection biases may have precluded accurate analysis. Efforts to increase ANC utilization may be a worthwhile investment to increase SAB...
  47. pmc Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda
    Eugene Mutimura
    aRegional Alliance for Sustainable Development, Kigali, Rwanda bCUNY School of Public Health, New York cAlbert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York dThe State University of New Jersey, New Brunswick, New Jersey, USA eRwanda Military Hospital, Kigali fMasaka District Hospital, Kigali gCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda hInstitute of HIV AIDS and Disease Prevention and Control, Rwanda Biomedical Center Kigali, Rwanda iCUNY School of Public Health and Hunter College, New York, New York, USA
    AIDS 29:67-76. 2015
    ..This study was conducted to better understand barriers and enablers to timely ART initiation in Rwanda where ART coverage is high and national ART eligibility guidelines first expanded in 2007-2008...
  48. pmc Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
    Trop Med Int Health 13:870-9. 2008
    ..To describe temporal trends in baseline clinical characteristics, initial treatment regimens and monitoring of patients starting antiretroviral therapy (ART) in resource-limited settings...
  49. ncbi request reprint Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004
    Michael F Schneider
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD 21205, USA
    AIDS 19:2009-18. 2005
    ..To characterize changing survival patterns after development of clinical AIDS from 1984 to 2004, when different antiretroviral therapies were being introduced...
  50. pmc Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women
    Judith A Cook
    Mental Health Services Research Program, Department of Psychiatry, University of Illinois at Chicago, 104 S Michigan Ave, Suite 900, Chicago, IL 60603, USA
    Am J Public Health 92:82-7. 2002
    ..This study examined longitudinal trends in use of highly active antiretroviral therapy (HAART) among a cohort of HIV-positive participants in the Women' Interagency HIV Study...
  51. pmc Awareness of hepatitis C infection among women with and at risk for HIV
    Mardge H Cohen
    CORE Center, Cook County Bureau of Health Services, Chicago, IL, USA
    J Gen Intern Med 22:1689-94. 2007
    ..Treatment guidelines recommend all HIV/HCV-co-infected persons be considered for hepatitis C virus (HCV) treatment, yet obstacles to testing and accessing treatment for HCV continue for women...
  52. ncbi request reprint Good news for women living with HIV
    Kathryn Anastos
    J Infect Dis 196:971-3. 2007
  53. ncbi request reprint Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study
    Lynn M Kirstein
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Room E 7007, Baltimore, MD 21205, U S A
    J Acquir Immune Defic Syndr 29:495-503. 2002
    ..The purpose of this study was to describe the variability in highly active antiretroviral therapy (HAART) regimens over time, the extent to which individuals switch, and the characteristics of those who are switching...
  54. ncbi request reprint Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    Obstet Gynecol 104:1077-85. 2004
    ..We sought to estimate rates of progression and regression of grade 1 cervical intraepithelial neoplasia (CIN 1) among women with human immunodeficiency virus (HIV)...
  55. ncbi request reprint Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies
    Stephen R Cole
    Department of Epidemiology, Johns Hopkins University, Baltimore, MD 21205, USA
    Stat Med 23:3351-63. 2004
    ..70; 95 per cent CI 0.35, 1.42). Methods presented here offer an approach to analysing prevalent cohort studies and provide procedures to maximize the usefulness of observational data...
  56. ncbi request reprint Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy
    Lynda Anne Szczech
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Clin Infect Dis 39:1199-206. 2004
    ..The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described...
  57. pmc CCR2 genotype and disease progression in a treated population of HIV type 1-infected women
    Sean Philpott
    Wadsworth Center, New York State Department of Health, Albany, NY, USA
    Clin Infect Dis 39:861-5. 2004
    ..No association was seen between CCR2 genotype and either disease progression or therapeutic response, suggesting that the benefits of treatment most likely overshadow the salutary effects of the V64I polymorphism...
  58. pmc Evolution of human immunodeficiency virus type 1 coreceptor usage during antiretroviral Therapy: a Bayesian approach
    Christina M R Kitchen
    Department of Biostatistics, UCLA School of Public Health, Los Angeles, CA 90095 1772
    J Virol 78:11296-302. 2004
    ..This model is not limited to analyses of HIV-1 but can be used to elucidate evolutionary processes for other organisms as well...
  59. ncbi request reprint Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection
    Audrey L French
    CORE Center Cook County Hospital, Rush Medical College, Chicago, IL 60612, USA
    Clin Infect Dis 39:402-10. 2004
    ..65% to increases of 7.57% of the ULN per year; P values of.19-.71). Our findings lend support to assertions that antiretroviral therapy is safe for women with HCV infection...
  60. ncbi request reprint Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy
    Yolanda Barron
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    AIDS 18:1579-84. 2004
    ..To estimate the effect of discontinuing antiretroviral therapy (ART) on survival, among women who initiated highly active antiretroviral therapy (HAART)...
  61. ncbi request reprint Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women
    Howard Minkoff
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York, USA
    J Infect Dis 189:1821-8. 2004
    ..Among HIV-infected women, smoking is associated with a significantly higher prevalence and incidence of HPV infection. Smoking during HIV infection may alter the natural history of HPV infection and increase the risk of cervical disease...
  62. ncbi request reprint Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University, Springfield, Illinois, 62794 9640, USA
    AIDS 18:281-6. 2004
    ..To determine frequency and outcomes of pregnancy in US women with HIV before and after introduction of highly active antiretroviral therapy (HAART)...
  63. ncbi request reprint HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois School of Medicine, Springfield, Illinois 62794, USA
    J Womens Health (Larchmt) 13:147-53. 2004
    ....
  64. pmc CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women
    Sean Philpott
    Wadsworth Center, New York State Department of Health, Albany, New York 12208, USA
    J Infect Dis 187:569-75. 2003
    ..Because Delta 32 is rare in Africans and Asians, it seems plausible that differential genetic susceptibility, in addition to social and behavioral factors, may contribute to the rapid heterosexual spread of HIV-1 in Africa and Asia...
  65. ncbi request reprint Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models
    Stephen R Cole
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Epidemiol 158:687-94. 2003
    ..Standard Cox analysis failed to detect a clear net benefit, because it does not appropriately adjust for time-dependent covariates, such as HIV RNA level and CD4 cell count, that are simultaneously confounders and intermediate variables...
  66. ncbi request reprint Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women
    Helen E Cejtin
    Department of Obstetrics and Gynecology, Cook County Hospital, Chicago, IL, USA
    AIDS 17:1702-4. 2003
    ..There did not appear to be an association between hormonal contraception use and HIV-1-RNA levels in our study. There was a small increase in CD4 cell counts among hormonal users of doubtful clinical significance...
  67. ncbi request reprint Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women
    Jessica E Justman
    Bronx Lebanon Hospital Center, New York 10457, USA
    J Acquir Immune Defic Syndr 32:298-302. 2003
    ..To assess the association between protease inhibitor (PI) use and the incidence of diabetes mellitus (DM) among participants in the Women's Interagency HIV Study...
  68. ncbi request reprint The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts
    Michael J Silverberg
    Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA
    Sex Transm Dis 29:427-35. 2002
    ..HIV infection and associated immunodeficiency are known to alter the course of human papillomavirus (HPV) infections and of associated diseases...
  69. ncbi request reprint Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women
    Judith A Cook
    Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois 60603, USA
    J Acquir Immune Defic Syndr 30:401-9. 2002
    ..These findings suggest that efforts to enhance women's access to psychological treatment may increase their use of the latest HIV therapies...
  70. pmc Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy
    Mardge H Cohen
    Department of Medicine, Cook County Hospital, Chicago, Illinois, USA
    Am J Med 113:91-8. 2002
    ..To examine changes in the causes of death and mortality in women with human immunodeficiency virus (HIV) infection in the era of combination antiretroviral therapy...
  71. ncbi request reprint Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Acquir Immune Defic Syndr 37:1604-9. 2004
    ..Herpes zoster occurs at all CD4 cell counts in HIV-infected adults. It was hypothesized that even in the era of highly active antiretroviral therapy (HAART), zoster risk is higher in HIV-infected than uninfected women...
  72. ncbi request reprint Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study
    Kathleen Mulligan
    University of California, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 38:18-22. 2005
    ..0004 vs. HIV-negative). Thus, consistent with reports in men, lower levels of peripheral (leg) fat are seen in HIV-infected women on HAART, despite the high prevalence of obesity in this population...
  73. ncbi request reprint HIV-1 drug resistance in variants from the female genital tract and plasma
    Kimdar Sherefa Kemal
    Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
    J Infect Dis 195:535-45. 2007
    ..Human immunodeficiency virus type 1 (HIV-1) drug-resistance mutations may arise in a fraction of viral variants, and these variants may differ between compartments, including the genital tract and blood...
  74. ncbi request reprint Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study
    Nancy A Hessol
    Department of Medicine, University of California, San Francisco, CA 94122, USA
    Clin Infect Dis 44:287-94. 2007
    ..We examined temporal trends and risk factors for accident- and injury-related mortality among HIV-infected and -uninfected participants in the Women's Interagency HIV Study (WIHS) and the Multicenter AIDS Cohort Study (MACS)...
  75. ncbi request reprint Does patient-provider racial/ethnic concordance influence ratings of trust in people with HIV infection?
    Nancy Lynn Sohler
    Sophie Davis Medical School, City University of New York, 138th Street and Convent Avenue, City College Campus, New York, NY 10031, USA
    AIDS Behav 11:884-96. 2007
    ....
  76. pmc Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women
    Judith A Cook
    Center on Mental Health Services Research and Policy, Department of Psychiatry M C 912, University of Illinois at Chicago, 1601 W Taylor Street M C 912, Chicago, IL 60612, USA
    Drug Alcohol Depend 89:74-81. 2007
    ..We examined the interaction of illicit drug use and depressive symptoms, and how they affect the subsequent likelihood of highly active antiretroviral therapy (HAART) use among women with HIV/AIDS...
  77. pmc Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women
    David B Seifer
    Maimonides Medical Center, Department of Obstetrics and Gynecology, Brooklyn, New York, USA
    Fertil Steril 88:1645-52. 2007
    ..To determine whether HIV infection influences early follicular MIS levels, an early marker of ovarian aging...
  78. ncbi request reprint Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction
    Helen E Cejtin
    John H Stroger Hospital of Cook County, Chicago, Illinois 60626, and University of California, San Francisco, San Francisco, California, USA
    Obstet Gynecol 108:1423-31. 2006
    ..To characterize ovarian failure and prolonged amenorrhea from other causes in women who are both human immunodeficiency virus (HIV) seropositive and seronegative...
  79. ncbi request reprint Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women
    L Stewart Massad
    Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    J Womens Health (Larchmt) 15:591-8. 2006
    ..To describe menstrual abnormalities among women with HIV...
  80. pmc Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study
    Joseph G Feldman
    SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, USA
    Am J Public Health 96:1060-5. 2006
    ..We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women...
  81. pmc Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women
    Carlos M Vaamonde
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 22:222-31. 2006
    ..We conclude that higher baseline CD4 count and lower HIV RNA level were associated with poor immunologic response to HAART in women with virologic suppression for at least 6 months. Persistent low level viremia may also contribute...
  82. ncbi request reprint Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model
    Stephen R Cole
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Am J Epidemiol 166:219-27. 2007
    ..In conclusion, the clinically important protective effect of HAART on dampening viral load appears to be rapid, present at CD4 cell counts greater than 350 cells/mm(3), and sustained beyond 6 years...
  83. ncbi request reprint Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study
    Kiros Berhane
    Keck School of Medicine, University of Southern California, Los Angeles, CA 90089 9011, USA
    J Acquir Immune Defic Syndr 37:1245-52. 2004
    ..Anemia is common in HIV-infected individuals and may be associated with decreased survival...
  84. ncbi request reprint Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women
    Ann Danoff
    Harbor Health Care Manhattan, VAH and New York University School of Medicine, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 39:55-62. 2005
    ..To assess the frequency of diabetes, prediabetes, and insulin resistance among a subset of participants in the Women's Interagency HIV Study (WIHS)...
  85. ncbi request reprint Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794 9640, USA
    J Low Genit Tract Dis 11:90-7. 2007
    ..To describe outcomes after treatment of cervical intraepithelial neoplasia (CIN) in women with HIV...
  86. ncbi request reprint Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women
    Mariana Lazo
    Johns Hopkins University Bloomberg School of Public Health, Epidemiology, Baltimore, MD 21205, USA
    Clin Infect Dis 45:1377-85. 2007
    ..Adherence to therapy is a dynamic behavior. However, few studies have identified factors associated with changes in adherence to highly active antiretroviral therapy (HAART) among men and women...
  87. ncbi request reprint Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women's Interagency HIV Study
    Ann Khalsa
    University of Southern California, Los Angeles, California, USA
    AIDS 21:2539-41. 2007
    ..0001), and body mass index greater than 30 kg/m (P < 0.0001), whereas current pregnancy was protective (P < 0.04). HIV infection, CD4 cell count, HIV-1 viral load, and antiretroviral therapy were not associated with hypertension...
  88. pmc HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation
    Kimdar Sherefa Kemal
    New York State Department of Health, Wadsworth Center, 120 New Scotland Avenue, Albany, NY 12208, USA
    Proc Natl Acad Sci U S A 100:12972-7. 2003
    ..These findings are relevant to the prevention and control of HIV-1 infection...
  89. ncbi request reprint Serum albumin is a powerful predictor of survival among HIV-1-infected women
    Joseph G Feldman
    State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203, USA
    J Acquir Immune Defic Syndr 33:66-73. 2003
    ..We now extend this to the use of serial measurements and single albumin values prior to initiation of highly active antiretroviral therapy...
  90. ncbi request reprint Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy
    Jaclyn H Chu
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Am J Epidemiol 161:881-90. 2005
    ..517, p = 0.751, and p = 0.218, respectively) after HAART initiation. In conclusion, the authors did not find substantial evidence that use of hormonal contraceptives strongly affected responses to HAART...
  91. doi request reprint Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study
    Magdalena E Sobieszczyk
    Division of Infectious Diseases, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 48:272-80. 2008
    ..To assess the prevalence of metabolic syndrome (MetSynd) among participants of the Women's Interagency HIV Study and to describe the association of MetSynd with HIV infection, antiretroviral therapies, and sociodemographic factors...
  92. pmc Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women
    Jessica E Justman
    Department of Epidemiology, Columbia University, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 47:312-9. 2008
    ..Previous studies suggest that indicators of central adiposity such as waist-to-hip ratio (WHR) and waist circumference may be altered by HIV infection, antiretroviral treatment, or both...
  93. ncbi request reprint Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols
    Monica Gandhi
    Department of Medicine, University of California, San Francisco 94122, USA
    AIDS 19:1885-96. 2005
    ....
  94. pmc Increased circulating interleukin-7 levels in HIV-1-infected women
    Laura A Napolitano
    Gladstone Institute of Virology and Immunology, University of California at San Francisco, 94158, USA
    J Acquir Immune Defic Syndr 40:581-4. 2005
    ..0032) after controlling for CD4 count, age, and race. Given the important role of IL-7 in T-cell development and homeostasis, these findings suggest that higher IL-7 levels may contribute to higher CD4 counts in women...
  95. pmc Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status
    Akiko Kobayashi
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco, San Francisco, California 94143 0128, USA
    Am J Pathol 160:151-64. 2002
    ..In summary, the types of lymphoid follicle in lesions from HIV-positive women were significantly different from those from HIV-negative women, and these differences are associated with the worse clinical outcome in HIV-positive women...